Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways: Melatonin stimulates osteoblastic differentiation
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Although melatonin has a variety of biological actions such as antitumor, antiangiogenic, and antioxidant activities, the osteogenic mechanism of melatonin still remains unclear. Thus, in the present study, the molecular mechanism of melatonin was elucidated in the differentiation of mouse osteoblastic MC3T3-E1 cells. Melatonin enhanced osteoblastic differentiation and mineralization compared to untreated controls in preosteoblastic MC3T3-E1 cells. Also, melatonin increased wound healing and dose-dependently activated osteogenesis markers such as runt-related transcription factor 2 (Runx2), osteocalcin (OCN), bone morphogenic protein (BMP)-2 and -4 in MC3T3-E1 cells. Of note, melatonin activated Wnt 5 α/β, β-catenin and the phosphorylation of c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) in a time-dependent manner while it attenuated phosphorylation of glycogen synthase kinase 3 beta (GSK-3β) in MC3T3-E1 cells. Consistently, confocal microscope observation revealed that BMP inhibitor Noggin blocked melatonin-induced nuclear localization of β-catenin. Furthermore, Western blotting showed that Noggin reversed activation of β-catenin and Wnt5 α/β and suppression of GSK-3β induced by melatonin in MC3T3-E1 cells, which was similarly induced by ERK inhibitor PD98059. Overall, these findings demonstrate that melatonin promotes osteoblastic differentiation and mineralization in MC3T3-E1 cells via the BMP/ERK/Wnt pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 3×
“reported recently that Sclerostin, a proven endogenous antagonist, blocks both BMP and Wnt signaling pathways by binding to BMP ligands [50, 51] or Wnt receptor LRP5 [52, 53].”
BackgroundSOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771
Linkage of Osteoporosis to Chromosome 20p12 and Association to BMP2
Styrkarsdottir, U., Cazier, J.-B., Kong, A., Rolfsson, O., Larsen, H., Bjarnadottir, E., Johannsdottir, V. D., Sigurdardottir, M. S., Bagger, Y., Christiansen, C., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000069 · Cited by 248 · cited 1×
“Wnt/b-catenin signaling pathway was reported to regulate bone mass through a number of mechanisms such as renewal of stem cells, stimulation of preosteoblast replication, induction of osteoblastogenesis, and inhibition of osteoblast and osteocyte apoptosis [6, 8].”
BackgroundWinkler, D. G., Sutherland, M. S. K., Ojala, E., Turcott, E., Geoghegan, J. C., Shpektor, D., Skonier, J. E., Yu, C., & Latham, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m400524200 · Cited by 164
Cited by
Is Melatonin the Cornucopia of the 21st Century?
Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M. G., Rizzo, V., Currò, M., Ientile, R., & Caccamo, D. (2020) · Antioxidants · doi:10.3390/antiox9111088 · Cited by 189
Insights into the role of circadian rhythms in bone metabolism: A promising intervention target?
Song, C., Wang, J., Kim, B., Lu, C., Zhang, Z., Liu, H., Kang, H., Sun, Y., Guan, H., Fang, Z., et al. (2018) · BioMed Research International · doi:10.1155/2018/9156478 · Cited by 66
Identification of a novel melatonin-binding nuclear receptor: Vitamin D receptor
Fang, N., Hu, C., Sun, W., Xu, Y., Gu, Y., Wu, L., Peng, Q., Reiter, R. J., & Liu, L. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12618 · Cited by 46
Investigational drugs for fracture healing: preclinical & clinical data
E. Klontzas, M., I. Kenanidis, E., J. MacFarlane, R., Michail, T., E. Potoupnis, M., Heliotis, M., Mantalaris, A., & Tsiridis, E. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1161757 · Cited by 32
Cao, Z., Fu, Y., Sun, X., Zhang, Q., Xu, F., & Li, Y. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.11.023 · Cited by 26
Metadata
- Authors
- Park, K.-H., Kang, J. W., Lee, E.-M., Kim, J. S., Rhee, Y. H., Kim, M., Jeong, S. J., Park, Y. G., & Hoon Kim, S.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2011-04-07
- Volume
- 51
- Issue
- 2
- Pages
- 187-194
- ISSN
- 0742-3098 (ISSN-L)
- OpenAlex
- W1545865644
- Cited by
- 205
- References
- 4
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways: Melatonin stimulates osteoblastic differentiation. https://app.cochat.ai/papers/10.1111/j.1600-079x.2011.00875.x
- The paper
- Park, K.-H., Kang, J. W., Lee, E.-M., Kim, J. S., Rhee, Y. H., Kim, M., Jeong, S. J., Park, Y. G., & Hoon Kim, S. (2011). Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways: Melatonin stimulates osteoblastic differentiation. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2011.00875.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.